|
|
Position:
Description:
Pliant Therapeutics is an early stage biopharmaceutical company focused on the discovery and development of novel therapies for fibrotic diseases. Founded by Third Rock Ventures with world-renowned academic th
Employer:
Pliant Therapeutics, Inc.
Description:
Responsibilities:
- Plan and execute experiments related to the evaluation of novel targets and signaling pathways.
- Make detailed observations, record and analyze data.
- Troubleshoot experiments.
- Advance drug discovery programs by interacting with other biologists, chemists and external collaborators.
- Contribute effectively to patent, report and scientific publication writing.
- May have the opportunity to manage one or more Research Associates.
Qualifications/Experience:
Job Requirements:
- PhD. in Biochemistry, Molecular Biology, Structural Biology, or related field.
- A minimum of 5 years of experience working in antibody engineering, preferably in the pharmaceutical or biotechnology industry.
- Experienced in antibody humanization and maturation
- In-depth knowledge of state-of-the-art technologies and methods for design and optimization of antibody and antibody-based therapeutics.
- Hands-on experiences with phage-display, yeast-display, and/or antibody engineering are required
- Strong molecular biology skills
- High level of creativity and productivity with strong problem solving skills.
- Ability to champion the biology efforts into new directions to achieve project milestones.
- Strong evidence of conceptual thinking, active follow through and vigorous scientific curiosity.
- Proven ability to work well with others in a dynamic and highly collaborative environment.
- Exceptional interpersonal, verbal and written communication skills
Location:
South San Francisco, CA
Contact:
careers@pliantrx.com
Post Date:
10/31/2018 2:00:58 PM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Submit a Text Ad
|